ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2023 Operating Results
IMMUNOGEN IS NOW PART OF ABBVIE
Together we will be working to make a remarkable impact for cancer patients and their communities of care, raising standards of care and advancing a dynamic oncology pipeline.